11-47343655-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000256.3(MYBPC3):​c.1091-31G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00934 in 1,567,034 control chromosomes in the GnomAD database, including 1,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 565 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 609 hom. )

Consequence

MYBPC3
NM_000256.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.145

Publications

1 publications found
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
MYBPC3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 4
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • left ventricular noncompaction 10
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-47343655-C-T is Benign according to our data. Variant chr11-47343655-C-T is described in ClinVar as Benign. ClinVar VariationId is 255623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.162 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYBPC3NM_000256.3 linkc.1091-31G>A intron_variant Intron 12 of 34 ENST00000545968.6 NP_000247.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYBPC3ENST00000545968.6 linkc.1091-31G>A intron_variant Intron 12 of 34 5 NM_000256.3 ENSP00000442795.1
MYBPC3ENST00000399249.6 linkc.1091-31G>A intron_variant Intron 11 of 33 5 ENSP00000382193.2
MYBPC3ENST00000544791.1 linkn.1091-31G>A intron_variant Intron 12 of 26 5 ENSP00000444259.1

Frequencies

GnomAD3 genomes
AF:
0.0473
AC:
7194
AN:
152004
Hom.:
560
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.165
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0169
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.0364
GnomAD2 exomes
AF:
0.0127
AC:
2542
AN:
200394
AF XY:
0.00943
show subpopulations
Gnomad AFR exome
AF:
0.173
Gnomad AMR exome
AF:
0.00800
Gnomad ASJ exome
AF:
0.00135
Gnomad EAS exome
AF:
0.0000614
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000339
Gnomad OTH exome
AF:
0.00621
GnomAD4 exome
AF:
0.00523
AC:
7394
AN:
1414916
Hom.:
609
Cov.:
36
AF XY:
0.00444
AC XY:
3107
AN XY:
699064
show subpopulations
African (AFR)
AF:
0.181
AC:
5959
AN:
32936
American (AMR)
AF:
0.00830
AC:
347
AN:
41824
Ashkenazi Jewish (ASJ)
AF:
0.000917
AC:
22
AN:
23990
East Asian (EAS)
AF:
0.0000515
AC:
2
AN:
38816
South Asian (SAS)
AF:
0.000563
AC:
45
AN:
79930
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43616
Middle Eastern (MID)
AF:
0.00814
AC:
40
AN:
4914
European-Non Finnish (NFE)
AF:
0.000237
AC:
258
AN:
1090290
Other (OTH)
AF:
0.0123
AC:
721
AN:
58600
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
336
672
1009
1345
1681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0476
AC:
7242
AN:
152118
Hom.:
565
Cov.:
32
AF XY:
0.0460
AC XY:
3421
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.165
AC:
6857
AN:
41436
American (AMR)
AF:
0.0168
AC:
257
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000456
AC:
31
AN:
67986
Other (OTH)
AF:
0.0360
AC:
76
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.573
Heterozygous variant carriers
0
258
516
773
1031
1289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0217
Hom.:
65
Bravo
AF:
0.0542
Asia WGS
AF:
0.0120
AC:
43
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.26
DANN
Benign
0.72
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7940442; hg19: chr11-47365206; COSMIC: COSV57026190; API